الفهرس Only 14 pages are availabe for public view
 |  | from | 162 |  |  |
| | | from | 162 | | |
Abstract
Viral hepatitis C is a major public health problem in Egypt with high prevalence of sero-positivity. As a lymphotropic virus, HCV is expected to be responsible for the lymphoproliferative disorders discovered in chronic patients either benign as autoimmune conditions or malignant expansions in B-Cell clones. The number of patients suffering from malignant lymphoproliferative disorders on top of HCV infection is rising as well. This retrospective study will address the clinical progress and management outcome in LPD patients with hepatitis C virus compared to patients with similar disease status but without HCV infection. The study will be carried on 96 patients in two pair-matched groups of patients with malignant Iymphoproliferative disorders (HCV vs Control)